It’s the time of year when people start turning on the heat, but the transition to dryer air can have some negative effects ...

Journalist Annie Lowrey has a rare disease that causes a near-constant itch that doesn't respond to most treatments. She ...

Election Day is here, and while the primary focus of most people will be getting to their polling precinct and casting their ...

Dosed first patient in Phase 2/3 DRAGON II trial of Tinlarebant for the treatment of Stargardt disease (STGD1)Pivotal global Phase 3 PHOENIX ...

Vitamin A is critical to normal vision but can accumulate as toxic byproducts in individuals affected with STGD1 and GA (the advanced form of dry age-related macular ... with 104 subjects in 11 ...

Discover the rise of cupping therapy for skin as a wellness trend, exploring its benefits for pain relief, recovery, stress ...

In the EMPOWER trials, emraclidine was well-tolerated with a safety profile comparable to that observed in the Phase 1b trial. The most commonly reported adverse events in EMPOWER-1 and EMPOWER-2, ...

Enrique Silla, Jeanologia CEO and founder, said the initial goal of laser technology remains the same today: to completely ...

The $2 billion repair of an aqueduct means the city is more dependent on the Croton Watershed, which was particularly dry ...

City of Darwin is working with DCOH to revitalise the heart of the city through the proposed development of a new Civic ...

Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...

Ka mate kāinga tahi, ka ora kāinga rua. An innovative Government trial will tailor support to people with a diverse range of complex needs to move out of emergency housing and into more permanent ...